ACLY and hepatocellular carcinoma: USP22 stabilizes PPARγ to increase ACC and ACLY expression, which leads to abnormal lipid metabolism, promoting lipid accumulation and tumorigenesis in HCC cells (this process is accompanied by Akt activation).